Home Cart 0 Sign in  
X

[ CAS No. 372-20-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 372-20-3
Chemical Structure| 372-20-3
Chemical Structure| 372-20-3
Structure of 372-20-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 372-20-3 ]

Related Doc. of [ 372-20-3 ]

Alternatived Products of [ 372-20-3 ]

Product Details of [ 372-20-3 ]

CAS No. :372-20-3 MDL No. :MFCD00002254
Formula : C6H5FO Boiling Point : -
Linear Structure Formula :- InChI Key :SJTBRFHBXDZMPS-UHFFFAOYSA-N
M.W : 112.10 Pubchem ID :9743
Synonyms :

Calculated chemistry of [ 372-20-3 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 28.42
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.37
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 1.95
Log Po/w (MLOGP) : 1.9
Log Po/w (SILICOS-IT) : 1.84
Consensus Log Po/w : 1.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.31
Solubility : 0.554 mg/ml ; 0.00494 mol/l
Class : Soluble
Log S (Ali) : -1.98
Solubility : 1.18 mg/ml ; 0.0105 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.04
Solubility : 1.02 mg/ml ; 0.0091 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 372-20-3 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P280-P301+P310-P305+P351+P338 UN#:2922
Hazard Statements:H227-H301+H311+H331-H314-H412 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 372-20-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 372-20-3 ]
  • Downstream synthetic route of [ 372-20-3 ]

[ 372-20-3 ] Synthesis Path-Upstream   1~66

  • 1
  • [ 372-20-3 ]
  • [ 75-36-5 ]
  • [ 331-25-9 ]
Reference: [1] Patent: US4578387, 1986, A,
  • 2
  • [ 372-20-3 ]
  • [ 385-01-3 ]
Reference: [1] Journal of the Chemical Society, 1928, p. 1881
[2] Journal of the Chemical Society, 1925, vol. 127, p. 1602[3] Journal of the Chemical Society, 1926, p. 159
[4] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 22, p. 6842 - 6851
  • 3
  • [ 372-20-3 ]
  • [ 446-36-6 ]
  • [ 385-01-3 ]
  • [ 394-41-2 ]
YieldReaction ConditionsOperation in experiment
27% at 15 - 26℃; for 1.5 - 2 h; 3-Fluorophenol (5Og, 446mmol, lequiv) is dissolved glacial acetic acid (250 mL) and nitric acid 99percent (29.8g, 468mmol, 1.05equiv) is added slowly over approximately 1 h, maintaining the temperature at 20-250C. After complete addition, the reaction mixture is stirred for 30-60 min at ambient temperature and disappearance of 3-fluorophenol is confirmed by HPLC. The mixture is quenched by addition of water (500 mL). The resulting mixture is extracted with cyclohexane (4*67mL) to remove most of the regioisomers. The combined organic phases are extracted with water (167mL) to recover any desired regioisomer. The combined aqueous phases are extracted with TBME (3*167 mL) TBME to recover the desired product. The TBME phase, containing the desired regioisomer, is washed with a 10percent solution of sodium carbonate (4* 10OmL) to remove any acetic acid.TBME is replaced by toluene by distillation at atmospheric pressure, resulting in a solution of the product in approximately 100 mL of toluene. The solution is slowly cooled down to ambient temperature, which led to the precipitation of the desired product. The product was collected by filtration. The solid was dried in an oven overnight to give the title compound in 29percent yield and 97.9percent purity by HPLC. 1H-NMR (399.822 MHz, DMSO) δ 11.49 (s, IH), 8.07 (m, IH), 6.84-6.76 (m, 2H). 19F-NMR (376.209MHz, DMSO) δ - 114.28. m/z LCMS (ESI -ve) 156.00 (M-H); Method B: 3-Fluorophenol (1 mol equiv) is dissolved glacial acetic acid (2.5 rel vol) and nitric acid99percent (1.16 mol equiv) is added slowly over approximately 1 h, maintaining the temperature at 20-250C. After complete addition, the reaction mixture is stirred for Ih at ambient temperature and disappearance of 3-fluorophenol is confirmed by HPLC. The mixture is quenched by addition of water (2.5 rel vol). The resulting mixture is extracted 7 times with cyclohexane (1.675 rel vol) to remove most of the regioisomers. The combined organic phases are extracted with water (1 rel vol) to recover any desired regioisomer. The <n="21"/>combined aqueous phases are extracted twice with TBME (2.5 rel vol) to recover the desired product. The combined TBME phases, containing the desired regioisomer, are washed three times with a solution of 3percent aqueous potassium carbonate (1.25 rel vol) to remove any acetic acid. The TBME solution is concentrated at atmospheric pressure, then activated charcoal (0.017 rel weight) is added along with toluene (4.0 rel vol). The TBME is totally removed by atmospheric distillation. The warm solution at 50-800C is filtered over a filteraid to remove any insoluble particles. The toluene solution is then cooled to 0-50C which led to the precipitation of the desired product which was collected by filtration. The crude product was washed with toluene (0.17 rel vol) and petroleum ether (0.25 rel vol). The solid was dried in an oven overnight to give the title compound in 27percent yield and 97.4percent purity by HPLC.Crude 3-fluoro-4-nitrophenol (1 mol eq) is heated up to 110-115°C in toluene (3.24 rel vol) for 30 minutes. The mixture is cooled to 80-1000C and filtered over filteraid to remove any insoluble particles. The solution is further cooled to 0-50C which led to the precipitation of the desired product which was collected by filtration. The crude product was washed with toluene (0.17 rel vol). The solid was dried in an oven overnight to give the title compound in 77percent yield (recrystallisation only) and 99.2percent purity by HPLC. 1H-NMR (399.822 MHz, DMSO) δ 11.49 (s, IH), 8.07 (m, IH), 6.84-6.76 (m, 2H). 19F-NMR (376.209MHz, DMSO) δ -114.28. m/z LCMS (ESI -ve) 156.00 (M-H)
Reference: [1] Patent: WO2009/35407, 2009, A1, . Location in patent: Page/Page column 8; 19-20
  • 4
  • [ 372-20-3 ]
  • [ 7664-93-9 ]
  • [ 385-01-3 ]
  • [ 361-47-7 ]
  • [ 361-48-8 ]
Reference: [1] Journal of the Chemical Society, 1928, p. 1881
[2] Journal of the Chemical Society, 1925, vol. 127, p. 1602[3] Journal of the Chemical Society, 1926, p. 159
  • 5
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 38226-10-7 ]
  • [ 348-28-7 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994, # 13, p. 1823 - 1832
[2] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1429 - 1438
[3] Patent: CN104557654, 2017, B, . Location in patent: Paragraph 0086-0088
  • 6
  • [ 372-20-3 ]
  • [ 38226-10-7 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 19, p. 2925 - 2929
[2] Patent: US2017/37038, 2017, A1,
  • 7
  • [ 372-20-3 ]
  • [ 446-38-8 ]
Reference: [1] Heterocycles, 1992, vol. 34, # 12, p. 2301 - 2311
  • 8
  • [ 372-20-3 ]
  • [ 1077-01-6 ]
Reference: [1] Journal of Fluorine Chemistry, 2017, vol. 203, p. 130 - 135
  • 9
  • [ 372-20-3 ]
  • [ 394-41-2 ]
Reference: [1] Heterocycles, 1992, vol. 34, # 12, p. 2301 - 2311
[2] Patent: WO2007/129960, 2007, A2, . Location in patent: Page/Page column 35-36
[3] Patent: CN105801433, 2016, A, . Location in patent: Paragraph 0020; 0023
  • 10
  • [ 372-20-3 ]
  • [ 446-36-6 ]
  • [ 385-01-3 ]
  • [ 394-41-2 ]
YieldReaction ConditionsOperation in experiment
27% at 15 - 26℃; for 1.5 - 2 h; 3-Fluorophenol (5Og, 446mmol, lequiv) is dissolved glacial acetic acid (250 mL) and nitric acid 99percent (29.8g, 468mmol, 1.05equiv) is added slowly over approximately 1 h, maintaining the temperature at 20-250C. After complete addition, the reaction mixture is stirred for 30-60 min at ambient temperature and disappearance of 3-fluorophenol is confirmed by HPLC. The mixture is quenched by addition of water (500 mL). The resulting mixture is extracted with cyclohexane (4*67mL) to remove most of the regioisomers. The combined organic phases are extracted with water (167mL) to recover any desired regioisomer. The combined aqueous phases are extracted with TBME (3*167 mL) TBME to recover the desired product. The TBME phase, containing the desired regioisomer, is washed with a 10percent solution of sodium carbonate (4* 10OmL) to remove any acetic acid.TBME is replaced by toluene by distillation at atmospheric pressure, resulting in a solution of the product in approximately 100 mL of toluene. The solution is slowly cooled down to ambient temperature, which led to the precipitation of the desired product. The product was collected by filtration. The solid was dried in an oven overnight to give the title compound in 29percent yield and 97.9percent purity by HPLC. 1H-NMR (399.822 MHz, DMSO) δ 11.49 (s, IH), 8.07 (m, IH), 6.84-6.76 (m, 2H). 19F-NMR (376.209MHz, DMSO) δ - 114.28. m/z LCMS (ESI -ve) 156.00 (M-H); Method B: 3-Fluorophenol (1 mol equiv) is dissolved glacial acetic acid (2.5 rel vol) and nitric acid99percent (1.16 mol equiv) is added slowly over approximately 1 h, maintaining the temperature at 20-250C. After complete addition, the reaction mixture is stirred for Ih at ambient temperature and disappearance of 3-fluorophenol is confirmed by HPLC. The mixture is quenched by addition of water (2.5 rel vol). The resulting mixture is extracted 7 times with cyclohexane (1.675 rel vol) to remove most of the regioisomers. The combined organic phases are extracted with water (1 rel vol) to recover any desired regioisomer. The <n="21"/>combined aqueous phases are extracted twice with TBME (2.5 rel vol) to recover the desired product. The combined TBME phases, containing the desired regioisomer, are washed three times with a solution of 3percent aqueous potassium carbonate (1.25 rel vol) to remove any acetic acid. The TBME solution is concentrated at atmospheric pressure, then activated charcoal (0.017 rel weight) is added along with toluene (4.0 rel vol). The TBME is totally removed by atmospheric distillation. The warm solution at 50-800C is filtered over a filteraid to remove any insoluble particles. The toluene solution is then cooled to 0-50C which led to the precipitation of the desired product which was collected by filtration. The crude product was washed with toluene (0.17 rel vol) and petroleum ether (0.25 rel vol). The solid was dried in an oven overnight to give the title compound in 27percent yield and 97.4percent purity by HPLC.Crude 3-fluoro-4-nitrophenol (1 mol eq) is heated up to 110-115°C in toluene (3.24 rel vol) for 30 minutes. The mixture is cooled to 80-1000C and filtered over filteraid to remove any insoluble particles. The solution is further cooled to 0-50C which led to the precipitation of the desired product which was collected by filtration. The crude product was washed with toluene (0.17 rel vol). The solid was dried in an oven overnight to give the title compound in 77percent yield (recrystallisation only) and 99.2percent purity by HPLC. 1H-NMR (399.822 MHz, DMSO) δ 11.49 (s, IH), 8.07 (m, IH), 6.84-6.76 (m, 2H). 19F-NMR (376.209MHz, DMSO) δ -114.28. m/z LCMS (ESI -ve) 156.00 (M-H)
Reference: [1] Patent: WO2009/35407, 2009, A1, . Location in patent: Page/Page column 8; 19-20
  • 11
  • [ 372-20-3 ]
  • [ 446-36-6 ]
  • [ 394-41-2 ]
Reference: [1] Journal of the Chemical Society, 1928, p. 1881
[2] Journal of the Chemical Society, 1925, vol. 127, p. 1602[3] Journal of the Chemical Society, 1926, p. 159
  • 12
  • [ 372-20-3 ]
  • [ 75-03-6 ]
  • [ 458-03-7 ]
Reference: [1] Bl. Acad. Belg., 1913, p. 262[2] Chem. Zentralbl., 1913, vol. 84, # II, p. 760
[3] Journal of Medicinal Chemistry, 1996, vol. 39, # 21, p. 4261 - 4274
  • 13
  • [ 372-20-3 ]
  • [ 584-08-7 ]
  • [ 75-03-6 ]
  • [ 458-03-7 ]
Reference: [1] Patent: US5593993, 1997, A,
  • 14
  • [ 372-20-3 ]
  • [ 80-40-0 ]
  • [ 458-03-7 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2002, vol. 75, # 4, p. 789 - 800
  • 15
  • [ 201230-82-2 ]
  • [ 372-20-3 ]
  • [ 345-29-9 ]
YieldReaction ConditionsOperation in experiment
41% at 175℃; for 5 h; Potassium carbonate (51.6 g, 373 mmol) was dried by heating at200 C for 12 h. This was treated with3-fluorophenol (16.5 g, 147 mmol) in a sealed container which was then pressurized with carbon monoxide to 61.2 bar (900psig). The reaction mixture was heated to175 C for 5 h. Subsequently, the reaction mixture was dissolved in water, acidified with concentrated hydrochloric acid, and filtered. The solid was washed with water, then hexanes. The, solid was then dissolved in EtOAc, dried over magnesium sulfate, and concentrated to give 12 g of solid. This crude solid was purified by flash chromatography using, CHC13/MeOH/HOAc (98/1/1) to give 11 g of a white solid which was recrystallized from toluene to give the title compound (9.5 g,41percent) as needle solids. 1NMR <Desc/Clms Page number 40>FD-MS, m/e 155(m-1) Analysis forC7H5FO3-0.1C7H8-0.3H2O :Calcd: C, 54.17 ; H, 3.78 ;Found: C, 54.12 ; H, 3.39
Reference: [1] Patent: WO2005/49604, 2005, A2, . Location in patent: Page/Page column 39-40
[2] Patent: WO2006/57845, 2006, A1, . Location in patent: Page/Page column 44
  • 16
  • [ 372-20-3 ]
  • [ 345-29-9 ]
Reference: [1] Journal of the Chemical Society, 1929, p. 1639
  • 17
  • [ 372-20-3 ]
  • [ 51788-80-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 20, p. 4150 - 4160
[2] Journal of Medicinal Chemistry, 1988, vol. 31, # 8, p. 1590 - 1595
  • 18
  • [ 372-20-3 ]
  • [ 363-52-0 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 30, p. 6217 - 6229
  • 19
  • [ 372-20-3 ]
  • [ 54788-19-1 ]
Reference: [1] Journal of Fluorine Chemistry, 1995, vol. 70, # 1, p. 39 - 44
  • 20
  • [ 372-20-3 ]
  • [ 75-36-5 ]
  • [ 701-83-7 ]
Reference: [1] Advanced Synthesis and Catalysis, 2011, vol. 353, # 2-3, p. 426 - 442
[2] Pharmacy and Pharmacology Communications, 1999, vol. 5, # 5, p. 323 - 329
[3] Journal of the American Chemical Society, 1963, vol. 85, p. 709 - 724
[4] Journal of Medicinal Chemistry, 1988, vol. 31, # 8, p. 1590 - 1595
[5] Journal of Medicinal Chemistry, 1999, vol. 42, # 20, p. 4150 - 4160
[6] Patent: US6355796, 2002, B1,
[7] Patent: US6140270, 2000, A,
[8] Patent: EP908457, 1999, A1,
[9] Patent: US6191275, 2001, B1,
[10] Patent: WO2004/108720, 2004, A1, . Location in patent: Page 60; 61
[11] Journal of Medicinal Chemistry, 2014, vol. 57, # 15, p. 6458 - 6467
  • 21
  • [ 372-20-3 ]
  • [ 108-24-7 ]
  • [ 701-83-7 ]
YieldReaction ConditionsOperation in experiment
10.5 g at 120℃; 3-Fluorophenol (10 g, 89 mmol) was dissolved in 90 mmol acetic anhydride. 3 drops of concentrated sulfuric acid are added and the temperature rises to 120°C. cold After that time, the mixture was poured into 100 ml of ice-water solution containing 1 g of NaHCO 3 and extracted with ethyl acetate. The extract was washed with saturated NaHCO3 solution, dried over Na2SO4, and dried in vacuo to give 10.5 g of product for the next step.
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 5, p. 2241 - 2249
[2] Journal of Medicinal Chemistry, 1987, vol. 30, # 5, p. 814 - 820
[3] Journal of Medicinal Chemistry, 2018, vol. 61, # 7, p. 3037 - 3058
[4] Patent: CN105085427, 2018, B, . Location in patent: Paragraph 0331; 0333; 0335; 0336
  • 22
  • [ 372-20-3 ]
  • [ 701-83-7 ]
Reference: [1] Patent: EP1150962, 2004, B1, . Location in patent: Page 33
  • 23
  • [ 455-36-7 ]
  • [ 372-20-3 ]
  • [ 701-83-7 ]
Reference: [1] Advanced Synthesis and Catalysis, 2005, vol. 347, # 7-8, p. 1027 - 1034
  • 24
  • [ 108-05-4 ]
  • [ 372-20-3 ]
  • [ 701-83-7 ]
Reference: [1] Tetrahedron, 1992, vol. 48, # 12, p. 2477 - 2482
  • 25
  • [ 372-20-3 ]
  • [ 79-11-8 ]
  • [ 404-98-8 ]
Reference: [1] Journal of the American Chemical Society, 1943, vol. 65, p. 1555
[2] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 14, p. 4336 - 4347
[3] Journal of Heterocyclic Chemistry, 2016, vol. 53, # 1, p. 183 - 187
  • 26
  • [ 372-20-3 ]
  • [ 105-36-2 ]
  • [ 404-98-8 ]
Reference: [1] Patent: WO2014/100730, 2014, A1, . Location in patent: Paragraph 00262
  • 27
  • [ 372-20-3 ]
  • [ 96-32-2 ]
  • [ 404-98-8 ]
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 29, p. 4383 - 4387
  • 28
  • [ 372-20-3 ]
  • [ 404-98-8 ]
Reference: [1] Journal of Fluorine Chemistry, 2006, vol. 127, # 2, p. 291 - 295
[2] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 1, p. 173 - 179
[3] Bulletin of the Korean Chemical Society, 2015, vol. 36, # 10, p. 2549 - 2552
  • 29
  • [ 372-20-3 ]
  • [ 458-52-6 ]
Reference: [1] Heterocycles, 1992, vol. 34, # 12, p. 2301 - 2311
  • 30
  • [ 372-20-3 ]
  • [ 399-95-1 ]
Reference: [1] Journal of the Chemical Society, 1941, p. 645
[2] Patent: CN105801433, 2016, A,
  • 31
  • [ 127682-43-3 ]
  • [ 372-20-3 ]
  • [ 399-95-1 ]
  • [ 53981-24-1 ]
  • [ 53981-23-0 ]
Reference: [1] Journal of the American Chemical Society, 1992, vol. 114, # 25, p. 9795 - 9806
  • 32
  • [ 372-20-3 ]
  • [ 127-17-3 ]
  • [ 7423-96-3 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 3, p. 926 - 935
  • 33
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 348-28-7 ]
YieldReaction ConditionsOperation in experiment
72% With triethylamine; magnesium chloride In acetonitrile for 5 h; Heating / reflux [1042] To the mixture of 3-fluorophenol (10 mL, 102 mmole), anhydrous magnesium chloride (28.2 g, 744.6 mmole) in 500 mL of anhydrous acetonitrile was added anhydrous triethylamine (67 mL, 382. 5 mmole) and paraformaldehyde (22.3 g, 744.6 mmole). The mixture was then heated to reflux for five hours. After cooling to r. t, 500 mL of 5percent aqueous hydrochloric acid was added. The product was extracted with ethyl acetate. The combined organic extracts were washed with 5percent hydrochloric acid (x 3), brine, and dried over anhydrous magnesium sulfate. After removing the volatiles, the residue was a light pink solid. 11 g, yield 72percent. M. P: 67.5-69. 0°C. ESHRMS 777/Z 139.0211 (M-H, C7H4FO2 calc'd 139. 0201). 1H NMR (CDCl3/300MHz) 11.40 (s, 1H), 9.86 (s, 1H), 7.62-7. 57 (m, 1H), 6.79-6. 67 (m, 2H). 13C (CDC13/300MH) 195.4, 168.3 (d, J= 258 HZ), 164.4 (d, J=14. 9 Hz), 136.3 (d, J=12. 6 Hz), 118.2 (d, J= 2.0Hz), 108.5 (d, J= 23. 3 Hz), 104.9 (d, J=24. 4 HZ). L9F (CDCl3/400MHz) -97. 9 (m).
71% With triethylamine; magnesium chloride In acetonitrile for 4.25 h; Reflux To a mixture of 3-fluorophenol (415 mg, 3.70 mmol) and anhydrous MgCI2 powder (1 .06 g, 1 1 .1 mmol) in anhydrous acetonitrile (20 mL) was added anhydrous triethylamine (1 .94 mL) and paraformaldehyde (81 1 mg, 27.0 mmol). The mixture was heated to reflux for 4.25 h, during which time there was a colour change from white to pink to yellow. The reaction mixture was cooled to room temperature and 5percent aqueous HCI was added (20 mL). The product was extracted with EtOAc (2 x 50 mL) and the combined organic extracts washed with H20 (3 x 50 mL), brine (50 mL), dried over anhydrous MgS04 and the solvent removed in vacuo. FCC [dichloromethane-methanol (100:0)→(97:3)] of the crude residue afforded the title Preparation 1 (367 mg, 71 percent) as a white solid; Rf 0.83 (10percent MeOH:CH2CI2); H NMR (500 MHz, CDCI3) δ 1 1 .35 (1 H, d, J = 1 .6 Hz, CHO), 9.82 (1 H, s), 7.55 (1 H, dd, J = 6.3 and 8.6 Hz), 6.71 (1 H, dt, J = 2.4 and 8.3 Hz) and 6.66 (1 H, dd, J = 2.4 and 10.4 Hz), 19F NMR (470.7 MHz, CDCI3) δ -97.53 (m).
65% With magnesium chloride; trimethylamine In acetonitrile for 5 h; Reflux Example 81
Synthesis of 4-fluoro-2-hydroxybenzaldehyde
To a mixture of 3-fluorophenol (5 mL, 55.3 mmol), MgCl2 (14.2 g, 149 mmol) in dry acetonitrile (250 mL) was added dry trimethylamine (27 mL) and paraformaldehyde (11 g).
The resulted mixture was stirred at reflux for 5 h, and then cooled down to room temperature.
The reaction was quenched by addition of hydrochloric acid (5percent, 250 mL), extracted with ethyl acetate (100*3).
The combined organic layer was washed with hydrochloric acid (5percent), H2O and brine, dried over sodium sulfate and concentrated under vacuum.
The residue was purified by column chromatography on silica gel (petroleum ether:ethyl acetate=50:1˜20:1) to afford 4-fluoro-2-hydroxybenzaldehyde (5 g, yield: 65percent) as a light yellow solid.
1H NMR (400 MHz, CDCl3): δ 11.37 (d, J=1.6 Hz, 1H), 9.83 (s, 1H), 7.55-7.59 (m, 1H), 6.65-6.75 (m, 2H).
63% With triethylamine; magnesium chloride In acetonitrile at 80℃; for 19 h; To a solution of 3-fluorophenol (2.0 mL, 22.3 mmol) and triethylamine (11.7 mmol) in anhydrous CH3CN (50 mL) was added p- formaldehyde (4.52 g, 151 mmol) and MgCl2 (3.19 g, 33.5 mmol) ML, 83.6 mmol). The reaction mixture was refluxed at 80 & lt; 0 & gt; C for 19 hours. After confirming the reaction with TLC, the reaction mixture was cooled to room temperature, and 3N HCl was added to the reaction mixture to adjust the pH to 2. The organic layer was extracted with ethyl acetate and distilled water and washed with brine. The separated organic layer was dried over anhydrous magnesium sulfate and then decompressed to remove the solvent. The reaction mixture was purified by flash column chromatography (CH2Cl2: Hex = 1: 1, Rf = 0.4) to obtain 4-fluoro-2-hydroxyaldehyde (1.97 g, 63percent, white solid).
51.6%
Stage #1: With magnesium methanolate In methanol; toluene at 95℃; for 3 h;
Stage #2: With sulfuric acid In methanol; water; toluene for 2 h;
Preparation of intermediate (1) : 4-fluoro-2-hvdroxy-benzaldehyde: 4-Fluorophenol (5.0ml, 56.02mmol) and magnesium methoxide (44.5ml, 33.6mmol, 8percent wt in MeOH) were dissolved in methanol (30ml). Thereafter the reaction mixture was distilled until the methanol was left over about 15ml. thereto the reaction mixture was added toluene (42ml), and distilled when the reaction temperature was reached 950C. p-Formaldehyde (5.18g, 172.54mmol) was slowly added for 1 hour, and then the reaction mixture was distilled at 95°C for 1 hour. Additionally the reaction mixture was stirred at the same temperature for 1 hour and cooled down room temperature. Then 10percent sulfuric acid was added, stirred for 2 hours and aqueous layer was extract with toluene. Combined organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by column chromatography (n-hexane: ethyl acetate = 8:1) to give 4.05g (yield: 51.6percent, yellow solid) of the target compound. 1H-NMR (CDCl3, 400MHz) 11.37(s, IH), 9.84(s, IH), 7.57(dd, 7=8.6, 6.4Hz, IH), 6.66~6.76(m, 2H)
36%
Stage #1: With ethylmagnesium bromide In tetrahydrofuran at 20℃; for 2 h;
Stage #2: With triethylamine In benzene for 3 h; Heating / reflux
Stage #3: With hydrogenchloride; water In benzene at 20℃;
Step 1 4-Fluoro-2-hydroxy-benzaldehyde; To a solution of 3-fluorophenol (1 ml, 11 mmol) in THF(20 ml) in a three-neck flask was added ethylmagnesium bromide (5.5 ml, 5.5 mmol, IM in THF). After stirring at room temperature for 2 hours, benzene was added to the reaction mixture and THF was removed by distillation at 8O0C. Additional benzene (50 ml) was added to the reaction, followed by NEt3 (2.3 ml, 16.5 mmol) and paraformaldehyde (Ig, 33.3mmol). After heating at reflux for 3 hours, the reaction mixture was allowed to cool to room temperature and was poured into 250 ml of 10percent HCl. EtOAc was added and the organic layer was separated and washed with H2O. After drying over MgSO4, the solvent was removed under reduced pressure. The resulting residue was purified by flash chromatography to give 4-fluoro-2 -hydroxy- EPO <DP n="44"/>benzaldehyde as a white solid (560mg, 36percent), 1H NMR (CDC13, 300 MHz)δ: 6.71 (m, 2H),7.56(dd, IH, J= 6.3Hz, 8.6Hz), 9.84(s, IH), 11.36(s, IH).
2.7 g With triethylamine; magnesium chloride In acetonitrile for 2.75 h; Reflux To the mixture of 3-fluorophenol (5 mL, 51 mmol) , anhydrous magnesium chloride (14.1 g, 372 mmol) in 250 mL of acetonitrile was added triethylamine (34 mL, 190 mmol) and paraforaldehyde (11 g, 372 mmol) . The mixture was then heated to reflux for 5 hours. After cooling to room temperature, 250 mL of 5 HCl. aq was added, extracted with EA (100 mL×2) . The combined organic layer was washed with 5 HCl. aq (100 mL×2) , brine, and dried over Na2SO4, concentrated, purified by chromatography column to give the desired product (2.7 g) .1H NMR (400 MHz, CDCl3) δ 11.36 (s, 1H) , 9.84 (s, 1H) , 7.54-7.58 (m, 1H) , 6.65-6.75 (m, 2H)

Reference: [1] Patent: WO2004/87686, 2004, A2, . Location in patent: Page 504
[2] Patent: WO2004/87687, 2004, A1, . Location in patent: Page 504
[3] Patent: WO2017/55860, 2017, A1, . Location in patent: Page/Page column 138-139
[4] Patent: US2017/37038, 2017, A1, . Location in patent: Paragraph 0375; 0376; 0377
[5] Patent: KR101679262, 2016, B1, . Location in patent: Paragraph 0156-0158
[6] Angewandte Chemie - International Edition, 2017, vol. 56, # 49, p. 15545 - 15549[7] Angew. Chem., 2017, vol. 129, # 49, p. 15751 - 15755,5
[8] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 24, p. 8618 - 8629
[9] Patent: WO2007/8037, 2007, A1, . Location in patent: Page/Page column 34
[10] Organic and Biomolecular Chemistry, 2017, vol. 15, # 6, p. 1530 - 1536
[11] Patent: WO2008/55808, 2008, A1, . Location in patent: Page/Page column 42-43
[12] Journal of Medicinal Chemistry, 2000, vol. 43, # 24, p. 4701 - 4710
[13] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5591 - 5593
[14] Patent: WO2013/91096, 2013, A1, . Location in patent: Page/Page column 37
[15] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 878 - 902
[16] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 15, p. 3057 - 3061
[17] Patent: WO2016/8411, 2016, A1, . Location in patent: Paragraph 0410
[18] Journal of Medicinal Chemistry, 2017, vol. 60, # 2, p. 627 - 640
[19] Chemistry - A European Journal, 2017, vol. 23, # 68, p. 17195 - 17198
[20] Organic Letters, 2017, vol. 19, # 23, p. 6340 - 6343
[21] Organic Letters, 2018, vol. 20, # 10, p. 2880 - 2883
  • 34
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 38226-10-7 ]
  • [ 348-28-7 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994, # 13, p. 1823 - 1832
[2] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1429 - 1438
[3] Patent: CN104557654, 2017, B, . Location in patent: Paragraph 0086-0088
  • 35
  • [ 372-20-3 ]
  • [ 109-88-6 ]
  • [ 348-28-7 ]
Reference: [1] Patent: US6642222, 2003, B2,
[2] Patent: US6593335, 2003, B1,
  • 36
  • [ 372-20-3 ]
  • [ 75-05-8 ]
  • [ 348-28-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 7, p. 2804 - 2812
  • 37
  • [ 372-20-3 ]
  • [ 348-27-6 ]
Reference: [1] Journal of Fluorine Chemistry, 1995, vol. 70, # 1, p. 39 - 44
  • 38
  • [ 372-20-3 ]
  • [ 3827-49-4 ]
Reference: [1] ACS Catalysis, 2018, vol. 8, # 5, p. 4033 - 4043
[2] Journal of the American Chemical Society, 1959, vol. 81, p. 94,95, 97
  • 39
  • [ 372-20-3 ]
  • [ 3827-49-4 ]
  • [ 348-60-7 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 21, p. 5476 - 5479
[2] Organic Letters, 2016, vol. 18, # 21, p. 5476 - 5479
  • 40
  • [ 372-20-3 ]
  • [ 3827-49-4 ]
  • [ 348-60-7 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 21, p. 5476 - 5479
[2] Organic Letters, 2016, vol. 18, # 21, p. 5476 - 5479
  • 41
  • [ 372-20-3 ]
  • [ 443-81-2 ]
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 9, p. 1007 - 1009
[2] Journal of the Chemical Society, 1929, p. 1639
[3] Journal of Organic Chemistry, 2005, vol. 70, # 16, p. 6548 - 6551
[4] Patent: EP1204660, 2004, B1,
  • 42
  • [ 372-20-3 ]
  • [ 7664-93-9 ]
  • [ 443-81-2 ]
Reference: [1] Journal of the Chemical Society, 1929, p. 1639
  • 43
  • [ 372-20-3 ]
  • [ 331-64-6 ]
Reference: [1] Journal of Fluorine Chemistry, 1995, vol. 70, # 1, p. 39 - 44
  • 44
  • [ 372-20-3 ]
  • [ 399-00-8 ]
Reference: [1] Journal of the Chemical Society, 1928, p. 2276
[2] Journal of the Chemical Society, 1929, p. 1639
[3] Patent: WO2013/91096, 2013, A1,
[4] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 878 - 902
[5] Journal of Medicinal Chemistry, 2017, vol. 60, # 2, p. 627 - 640
  • 45
  • [ 67-66-3 ]
  • [ 372-20-3 ]
  • [ 7726-95-6 ]
  • [ 399-00-8 ]
Reference: [1] Journal of the Chemical Society, 1928, p. 2276
[2] Journal of the Chemical Society, 1929, p. 1639
  • 46
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 77-78-1 ]
  • [ 450-83-9 ]
  • [ 146137-74-8 ]
YieldReaction ConditionsOperation in experiment
15.8 g
Stage #1: With magnesium chloride In acetonitrile for 0.0833333 h; Inert atmosphere; Molecular sieve
Stage #2: for 0.5 h; Inert atmosphere; Molecular sieve
The m-fluorophenol (20g, 0.2πο1) was dissolved in acetonitrile (500mL, dried over molecular sieves), protected by argon and anhydrous magnesium chloride (102g, l.lmol) was added with stirring. 5min. Triethylamine (225 mL, 1.6 mol) was added and the mixture was exothermic. After stirring for 30 min, paraformaldehyde (63 g, purchased from aldrich company, the same below) was added and reacted at 50 ° C. for 3 h. Finished reaction. 1N aqueous hydrochloric acid was added to adjust the pH to 4, and the mixture was extracted with ethyl acetate (3 × 150 mL). The combined organic phases were dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure (water chestnut) to give the crude product as a dark red oil B-la and aldehyde by-product) 49.9g, set curing. The crude product was dissolved in tetrahydrofuran (100 mL) and potassium carbonate (81.2 g, 0.6 mol) and dimethyl sulfate (25.4 mL, 0.3 mol) were added and reacted at 40 ° C overnight ), TLC showed the raw material has disappeared. The potassium carbonate was filtered off and the solid was washed with ethyl acetate (3 × 100 mL). The organic phases were combined, dried over anhydrous magnesium sulfate and concentrated. The residue was purified by column chromatography (using a 15: 1 volume ratio of ro / Et0Ac as eluant) Intermediate B-2a (15.8 g) and by-product 2-fluoro-6-methoxybenzaldehyde (2.8 g) all in the form of a light yellow solid with a total yield of 68percent 0B-2a: Mp: ° C; 6h (300ΜΗζ; CDC13) 10.4 (1Η, s), 7.85 (1Η, dd, J = 8.4Hz, 6.9Ηζ), 6.75-6.67 (2H, m), 3.93 (d, J = 11.0Ηζ), 130.9 (d, J = 11.6Ηζ), 121.6 (d, J = , J = 2.7Hz), 108.1 (d, J = 22.1Ηζ), 99.7 (d, J = 25.7Ηζ), 56.0.2-Fluoro-6-methoxy- benzaldehyde: Μρ: 60-61 ° C ; 6H (300 MΗζ; CDC13) 10.3 (1H, s), 7.41 (1H, dd, J = 15.0Ηζ, 8.4Ηζ), 6.71-6.61 (2H, m), 3.85 (3H, s) CDC13) 187.4 (d, J = 3.4 Hz), 163.3 (dJc, F = 260.5 Hz), 162.2 (d, J = 5.4Ηζ), 136.2 (d, J = 12.0Ηζ), 114.0 ), 108.6 (d, J = 21.3 Hz), 107.3 (d, J = 3.5Ηζ), 56.3.
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1429 - 1438
[2] Patent: CN104557654, 2017, B, . Location in patent: Paragraph 0086-0088
  • 47
  • [ 372-20-3 ]
  • [ 450-83-9 ]
Reference: [1] Journal of the Chemical Society, 1929, p. 1639
  • 48
  • [ 372-20-3 ]
  • [ 395-82-4 ]
Reference: [1] Journal of the Chemical Society, 1929, p. 1639
  • 49
  • [ 372-20-3 ]
  • [ 394-42-3 ]
Reference: [1] Molecular Crystals and Liquid Crystals (1969-1991), 1981, vol. 67, p. 1 - 24
  • 50
  • [ 127682-43-3 ]
  • [ 372-20-3 ]
  • [ 399-95-1 ]
  • [ 53981-24-1 ]
  • [ 53981-23-0 ]
Reference: [1] Journal of the American Chemical Society, 1992, vol. 114, # 25, p. 9795 - 9806
  • 51
  • [ 372-20-3 ]
  • [ 121219-03-2 ]
Reference: [1] Molecular Crystals and Liquid Crystals (1969-1991), 1981, vol. 67, p. 1 - 24
[2] New Journal of Chemistry, 2015, vol. 39, # 11, p. 8291 - 8301
[3] Journal of Materials Chemistry, 2001, vol. 11, # 6, p. 1590 - 1599
[4] Canadian Journal of Chemistry, 2011, vol. 89, # 3, p. 364 - 384
  • 52
  • [ 372-20-3 ]
  • [ 82380-18-5 ]
Reference: [1] Molecular Crystals and Liquid Crystals (1969-1991), 1981, vol. 67, p. 1 - 24
  • 53
  • [ 372-20-3 ]
  • [ 107-30-2 ]
  • [ 126940-10-1 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: With N-ethyl-N,N-diisopropylamine In dichloromethane at -10℃; for 0.25 h;
Stage #2: at -10 - 20℃; for 22.08 h;
A solution of 100 gm (0.892 mol) 3-fluorophenol in 800 ML dichloromethane was cooled to -10°C.
To this solution were added 155 gm (1.20 mol) diisopropylethylamine dropwise over 15 minutes..
Residual diisopropylethylamine in the addition funnel was rinsed into the reaction mixture with 100 ML dichloromethane..
To the resulting solution were added 100 gm (1.24 mol) chloromethyl methyl ether over 5 minutes, resulting an exotherm from -10°C to 2°C.
The reaction mixture was allowed to warm to room temperature..
After 22 hours the reaction mixture was quenched with 500 ML water..
The organic phase was washed with 500 ML 2M aqueous sodium bisulfate followed by 300 ML 1M sodium hydroxide..
The remaining organics were dried over magnesium sulfate and concentrated under reduced pressure to provide 130 gm of a yellow oil..
The oil was distilled (kugelrohr, 80°C, 0.1 torr) to provide 126 gm (91percent) of the desired compound as a colorless oil.
Reference: [1] ChemBioChem, 2015, vol. 16, # 17, p. 2445 - 2450
[2] Patent: EP1204660, 2004, B1, . Location in patent: Page 19
[3] European Journal of Organic Chemistry, 2001, # 15, p. 2911 - 2915
[4] Tetrahedron Letters, 2001, vol. 42, # 37, p. 6499 - 6502
[5] ChemMedChem, 2017, vol. 12, # 1, p. 23 - 27
  • 54
  • [ 109-87-5 ]
  • [ 372-20-3 ]
  • [ 126940-10-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1989, vol. 26, p. 1293 - 1298
  • 55
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 77-78-1 ]
  • [ 450-83-9 ]
  • [ 146137-74-8 ]
YieldReaction ConditionsOperation in experiment
15.8 g
Stage #1: With magnesium chloride In acetonitrile for 0.0833333 h; Inert atmosphere; Molecular sieve
Stage #2: for 0.5 h; Inert atmosphere; Molecular sieve
The m-fluorophenol (20g, 0.2πο1) was dissolved in acetonitrile (500mL, dried over molecular sieves), protected by argon and anhydrous magnesium chloride (102g, l.lmol) was added with stirring. 5min. Triethylamine (225 mL, 1.6 mol) was added and the mixture was exothermic. After stirring for 30 min, paraformaldehyde (63 g, purchased from aldrich company, the same below) was added and reacted at 50 ° C. for 3 h. Finished reaction. 1N aqueous hydrochloric acid was added to adjust the pH to 4, and the mixture was extracted with ethyl acetate (3 × 150 mL). The combined organic phases were dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure (water chestnut) to give the crude product as a dark red oil B-la and aldehyde by-product) 49.9g, set curing. The crude product was dissolved in tetrahydrofuran (100 mL) and potassium carbonate (81.2 g, 0.6 mol) and dimethyl sulfate (25.4 mL, 0.3 mol) were added and reacted at 40 ° C overnight ), TLC showed the raw material has disappeared. The potassium carbonate was filtered off and the solid was washed with ethyl acetate (3 × 100 mL). The organic phases were combined, dried over anhydrous magnesium sulfate and concentrated. The residue was purified by column chromatography (using a 15: 1 volume ratio of ro / Et0Ac as eluant) Intermediate B-2a (15.8 g) and by-product 2-fluoro-6-methoxybenzaldehyde (2.8 g) all in the form of a light yellow solid with a total yield of 68percent 0B-2a: Mp: ° C; 6h (300ΜΗζ; CDC13) 10.4 (1Η, s), 7.85 (1Η, dd, J = 8.4Hz, 6.9Ηζ), 6.75-6.67 (2H, m), 3.93 (d, J = 11.0Ηζ), 130.9 (d, J = 11.6Ηζ), 121.6 (d, J = , J = 2.7Hz), 108.1 (d, J = 22.1Ηζ), 99.7 (d, J = 25.7Ηζ), 56.0.2-Fluoro-6-methoxy- benzaldehyde: Μρ: 60-61 ° C ; 6H (300 MΗζ; CDC13) 10.3 (1H, s), 7.41 (1H, dd, J = 15.0Ηζ, 8.4Ηζ), 6.71-6.61 (2H, m), 3.85 (3H, s) CDC13) 187.4 (d, J = 3.4 Hz), 163.3 (dJc, F = 260.5 Hz), 162.2 (d, J = 5.4Ηζ), 136.2 (d, J = 12.0Ηζ), 114.0 ), 108.6 (d, J = 21.3 Hz), 107.3 (d, J = 3.5Ηζ), 56.3.
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1429 - 1438
[2] Patent: CN104557654, 2017, B, . Location in patent: Paragraph 0086-0088
  • 56
  • [ 127682-43-3 ]
  • [ 372-20-3 ]
  • [ 399-95-1 ]
  • [ 53981-24-1 ]
  • [ 53981-23-0 ]
Reference: [1] Journal of the American Chemical Society, 1992, vol. 114, # 25, p. 9795 - 9806
  • 57
  • [ 372-20-3 ]
  • [ 111141-00-5 ]
Reference: [1] Patent: WO2008/151927, 2008, A2,
  • 58
  • [ 372-20-3 ]
  • [ 68886-07-7 ]
Reference: [1] Molecular Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and Liquid Crystals, 1993, vol. 237, p. 399 - 406
  • 59
  • [ 372-20-3 ]
  • [ 75-36-5 ]
  • [ 98619-07-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1986, vol. 29, # 11, p. 2329 - 2334
  • 60
  • [ 372-20-3 ]
  • [ 65145-13-3 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
[2] Molecular Crystals and Liquid Crystals (1969-1991), 1981, vol. 67, p. 1 - 24
  • 61
  • [ 372-20-3 ]
  • [ 67531-86-6 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
[2] European Journal of Organic Chemistry, 2005, # 10, p. 2116 - 2123
[3] European Journal of Organic Chemistry, 2001, # 15, p. 2911 - 2915
  • 62
  • [ 590-92-1 ]
  • [ 372-20-3 ]
  • [ 113209-68-0 ]
Reference: [1] Patent: US6316437, 2001, B1,
  • 63
  • [ 372-20-3 ]
  • [ 113209-68-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2016, vol. 59, # 6, p. 2468 - 2477
[2] Patent: WO2008/151927, 2008, A2,
  • 64
  • [ 372-20-3 ]
  • [ 202857-89-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 24, p. 4701 - 4710
  • 65
  • [ 372-20-3 ]
  • [ 312314-26-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 24, p. 4701 - 4710
  • 66
  • [ 372-20-3 ]
  • [ 757251-39-1 ]
Reference: [1] Patent: CN105566215, 2016, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 372-20-3 ]

Fluorinated Building Blocks

Chemical Structure| 371-41-5

[ 371-41-5 ]

4-Fluorophenol

Similarity: 0.97

Chemical Structure| 75996-29-1

[ 75996-29-1 ]

5-Fluorobenzene-1,3-diol

Similarity: 0.94

Chemical Structure| 2713-34-0

[ 2713-34-0 ]

3,5-Difluorophenol

Similarity: 0.94

Chemical Structure| 2713-31-7

[ 2713-31-7 ]

2,5-Difluorophenol

Similarity: 0.91

Chemical Structure| 55660-73-6

[ 55660-73-6 ]

2-Fluorobenzene-1,4-diol

Similarity: 0.91

Aryls

Chemical Structure| 371-41-5

[ 371-41-5 ]

4-Fluorophenol

Similarity: 0.97

Chemical Structure| 75996-29-1

[ 75996-29-1 ]

5-Fluorobenzene-1,3-diol

Similarity: 0.94

Chemical Structure| 2713-34-0

[ 2713-34-0 ]

3,5-Difluorophenol

Similarity: 0.94

Chemical Structure| 2713-31-7

[ 2713-31-7 ]

2,5-Difluorophenol

Similarity: 0.91

Chemical Structure| 55660-73-6

[ 55660-73-6 ]

2-Fluorobenzene-1,4-diol

Similarity: 0.91